Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Amanda Maxwell

London, UK

A lifetime dedicated to passionately following medtech regulations seems a big claim, but Amanda Maxwell, regulatory affairs editor, wears the badge and has a loyal list of followers. She still remains as passionate about the implications of changing requirements as 30 years ago when analysing the drafting of the first EU medical device and IVD rules. She tirelessly picks through the draft and existing requirements and the implications of the background debate, to bring you the reality of what the latest developments and discussions mean for you. Amanda knows where to get the vital information, who can offer the best inside knowledge and how to get it to readers quickly. She is well respected in the industry and has a history of moderating and chairing at many high-profile meetings in the EU and the US ( MedTech Forum (EU), AdvaMed (US), DIA (EU and US)), and a strong network of contacts among regulators, consultants, lawyers and EU institutions. She has also been active in consulting and training companies in EU medical device regulations. Amanda has been known to pick up stories while swimming in the Aegean, and there are rumours of her renting a window cleaning scaffold outside the European Commission, but she won’t comment on this and would not recommend anyone to try it!

When not writing, Amanda is a strong well-being advocate and loves health and wellness apps. She rarely sits still and loves to be out and about, actively participating in life with family and friends.

Advertisement
Set Alert for Articles By Amanda Maxwell

Latest From Amanda Maxwell

European Commission Sorts Medtech Working Groups And Creates New One

The current European Commission medtech working group structure has evolved over the last 25 years. Now some changes are needed.

Europe Medical Device

MDR And IVDR Fail Risk-Benefit Assessment, EU Reg Expert Says

"I fail to see any merit in this piece of dismally bad legislation. It is absolutely in no one’s interest," says consultant and regulatory expert Jaap Laufer, who predicts disastrous impact on many companies and the end of notified bodies as we know them.

Europe Regulation

Will Brexit Negotiations Move To Devices Soon?

It's been a long and painful journey, but some progress has finally been made in Brexit talks. It is looking hopeful now that a "hard Brexit," or no-deal Brexit, is unlikely. Is there more good news coming for devices?

Brexit Medical Device

EMA Warns Device Sector That Relocation Could Hinder Device Approvals

The EMA does not just regulate drugs. It plays a vital role with some drug/device combination products and borderline products. Just as that role is expanding, relocation threatens to cause a hiatus for device-type products.

Europe Medical Device

Brexit Roundup: UK Medtech Balancing On A Fault Line

There are a growing number of conflicting opinions about what Brexit is going to mean to the EU medtech sector. Confusion seemed to grow throughout November, just when clarity is urgently needed. So, where are things heading?

Europe Medical Device

Expert Panel: How Manufacturers Are Paying For Notified Body Struggles

The increasingly challenging environment that EU notified bodies find themselves operating in is translating into some real headaches for device and diagnostics manufacturers. Here, three top EU medtech regulatory experts spell out the challenges.

Europe Medical Device
See All
Advertisement
UsernamePublicRestriction

Register